What is Profusa, Inc.'s market cap?

Profusa, Inc. (PFSA) has a market capitalization of $1.1M and trades on NASDAQ.

Who are Profusa, Inc.'s competitors?

Profusa, Inc.'s key competitors include Abbott, Medtronic, Senseonics, and others. These companies compete in similar markets and product categories.

Who does Profusa, Inc. partner with?

Profusa, Inc.'s notable partners include DARPA, National Institutes of Health, 3E Bioventures, and others.

Where is Profusa, Inc. headquartered?

Profusa, Inc. is headquartered in United States of America. It has been publicly traded since 2025.

Profusa, Inc. (PFSA) Stock Fundamentals & Financials

Profusa is a digital health technology company that develops a unique biosensor platform designed for real-time, long-term biochemistry monitoring.

Market cap

$1.08M-90.7%

Earnings

Q2 2026 report

August 19, 2026

EPS-$151.80

Read the full report

Next report

Date not yet announced

Competitors

By market cap

Abbott$177.12B-24.2%

Medtronic$118.45B-2.4%

DexCom$33.0B+9.9%

Philips$24.2B-8.9%

MiMedx Group$690.3M-32.8%

Senseonics Holdings, Inc.$479.0M+31.4%

Corvex$20.0M+260%

Profusa, Inc.$1.1M-90.7%

By revenue growth

Corvex+844%

Senseonics Holdings, Inc.+90.6%

By net margin

DexCom20.12%+6.8pp

Medtronic13.93%+0.3pp

Abbott11.65%-20.8pp

MiMedx Group1.76%-7.1pp

Senseonics Holdings, Inc.-225.31%+42.5pp

Corvex-623.49%+3,679pp

Profile

Profusa is a digital health technology company that develops a unique biosensor platform designed for real-time, long-term biochemistry monitoring. The company's core value proposition is its tissue-integrated hydrogel sensors that function for up to nine months without triggering the body's foreign body response, bridging the gap between clinical-grade diagnostics and consumer wearables.

Competitive position

Profusa differentiates itself through its proprietary hydrogel technology that avoids the 'foreign body response,' allowing for significantly longer sensor life than current market leaders.

GeographiesUnited States, European Union, Asia Pacific

Customer segmentsHealthcare Providers, Chronic Disease Patients, Enterprise Technology Partners

Business modelB2B, Hardware-as-a-Service, Data-driven services

SuppliersHydrogel material suppliers, Contract manufacturers, Sterilization service providers, Electronic component manufacturers

CustomersMedical distributors, Hospitals, Telemedicine platforms, Chronic disease patients

CountryUnited States of America

Listed2025

CEOJack E. Stover

SectorHealthcare

IndustryMedical - Devices

Websiteprofusa.com

FilingsSEC EDGAR

FAQ

What is Profusa, Inc.'s market cap?: Profusa, Inc. (PFSA) has a market capitalization of $1.1M and trades on NASDAQ.
Who are Profusa, Inc.'s competitors?: Profusa, Inc.'s key competitors include Abbott, Medtronic, Senseonics, and others. These companies compete in similar markets and product categories.
Who does Profusa, Inc. partner with?: Profusa, Inc.'s notable partners include DARPA, National Institutes of Health, 3E Bioventures, and others.
Where is Profusa, Inc. headquartered?: Profusa, Inc. is headquartered in United States of America. It has been publicly traded since 2025.